14-day Premium Trial Subscription Try For FreeTry Free
Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The top 3 positions are T-Mobile US, Amazon.com, and General Electric, together, at ~16% of the portfolio.

Zimmer (ZBH) Down 5.6% Since Last Earnings Report: Can It Rebound?

03:31pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Wide-Moat Stocks On Sale - The June 2022 Heat Map

07:20am, Tuesday, 31'st May 2022 Seeking Alpha
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison.
Upgrades According to Bernstein, the prior rating for HCA Healthcare Inc (NYSE:HCA) was changed from Market Perform to Outperform. HCA Healthcare earned $4.12 in the first quarter, compared to $4.14 i

5 Analysts Have This to Say About Zimmer Biomet Holdings

03:08pm, Friday, 27'th May 2022 Benzinga
Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 3 0 0

Zimmer Biomet Is Hobbling Behind The Market

08:54am, Wednesday, 25'th May 2022
Zimmer Biomet has greatly underperformed the S&P 500 as well as the iShares IHI, been stagnant over the past 5 years. The street consensus gives some hope for the projected growth with an estimated 28

Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now

04:01pm, Tuesday, 17'th May 2022 Zacks Investment Research
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.

Zimmer Biomet's (ZBH) Procedure Volume Grows, Costs Rise

03:16pm, Monday, 09'th May 2022 Zacks Investment Research
Zimmer Biomet's (ZBH) recently completed the spin-off of the non-core dental and spine business is expected to prove strategic.
Zimmer Biomet's (ZBH) recently completed the spin-off of the non-core dental and spine business is expected to prove strategic.
SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00. Shares of Zimmer Biomet Holdings are trading up 0.82%

Analyst Ratings for Zimmer Biomet Holdings

01:20pm, Wednesday, 04'th May 2022 Benzinga
Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 3 5 1 0

Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, FY22 View Up

02:48pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, whic
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE